Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
36,830
Sort by:
2024 Coagulation Testing Market Shares in 16 Countries--Competitive Analysis of Leading and Emerging Market Players
US$ 2,500.00
This new report provides coagulation testing market shares for the following countries: China, Egypt, France, Germany, India, Italy, Japan, Philippines, Russia, Saudi Arabia, South Korea, Spain, Thail...
March 2024
2024 Europe Hemostasis Analyzers and Reagents--France, Germany, Italy, Spain, UK--Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts for Hospitals, Commercial/Private Labs and POC Locations--2023 Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
This comprehensive five%li%country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing...
March 2024
